Area of research
Reproductive Medicine · Oncology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments, and CRISPR and Genetic Engineering.
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
The Malignant Potential of Ovarian Steroid Cell Tumors Revisited
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention
The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high‐grade serous carcinomas
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas